Total Payments
$9,888
2024 Payments
$2,399
Companies
24
Transactions
353
Medicare Patients
678
Medicare Billing
$102,056
Payment Breakdown by Category
Food & Beverage$9,072 (91.7%)
Other$625.19 (6.3%)
Education$190.63 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,072 | 341 | 91.7% |
| Debt forgiveness | $625.19 | 5 | 6.3% |
| Education | $190.63 | 7 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,560 | 45 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,391 | 43 | $0 (2024) |
| ABBVIE INC. | $1,176 | 65 | $0 (2024) |
| Neuronetics, Inc. | $1,111 | 14 | $0 (2024) |
| ITI, Inc. | $866.01 | 30 | $0 (2023) |
| Alkermes, Inc. | $606.29 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $491.77 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $436.26 | 17 | $0 (2024) |
| Corium, LLC | $388.37 | 12 | $0 (2024) |
| Lundbeck LLC | $374.63 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,399 | 77 | Neuronetics, Inc. ($625.19) |
| 2023 | $2,978 | 110 | Otsuka America Pharmaceutical, Inc. ($476.83) |
| 2022 | $3,032 | 109 | Janssen Pharmaceuticals, Inc ($509.59) |
| 2021 | $1,480 | 57 | Janssen Pharmaceuticals, Inc ($400.97) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $0.02 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 12/30/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $0.02 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 12/30/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $0.02 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 12/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Insomnia | ||||||
| 12/12/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $6.80 | General |
| Category: Narcoplepsy | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: CNS | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $139.45 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $86.21 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 110 | 320 | $57,640 | $18,207 |
| 2022 | 4 | 170 | 379 | $64,925 | $23,218 |
| 2021 | 5 | 398 | 1,039 | $153,075 | $60,630 |
Total Patients
678
Total Services
1,738
Medicare Billing
$102,056
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 147 | $27,200 | $9,513 | 35.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 146 | $20,990 | $6,192 | 29.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 27 | 27 | $9,450 | $2,502 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 140 | $25,720 | $9,784 | 38.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 44 | 155 | $21,550 | $6,977 | 32.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 33 | 33 | $11,395 | $4,137 | 36.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 19 | 19 | $2,280 | $945.06 | 41.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 18 | 18 | $2,160 | $740.68 | 34.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 14 | 14 | $1,820 | $635.60 | 34.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 116 | 390 | $46,800 | $19,144 | 40.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 108 | 110 | $30,800 | $13,042 | 42.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 70 | 237 | $30,810 | $10,534 | 34.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 30 | 119 | $16,100 | $5,873 | 36.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 19 | 90 | $10,800 | $4,491 | 41.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 28 | 28 | $8,235 | $3,829 | 46.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 32 | $6,175 | $2,674 | 43.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 16 | 33 | $3,355 | $1,043 | 31.1% |
About Chime Ajiere
Chime Ajiere is a Family healthcare provider based in Frankfort, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1851889018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chime Ajiere has received a total of $9,888 in payments from pharmaceutical and medical device companies, with $2,399 received in 2024. These payments were reported across 353 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($9,072).
As a Medicare-enrolled provider, Ajiere has provided services to 678 Medicare beneficiaries, totaling 1,738 services with total Medicare billing of $102,056. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Frankfort, IL
- Active Since 04/24/2018
- Last Updated 08/13/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851889018
Products in Payments
- SPRAVATO (Drug) $1,168
- VRAYLAR (Drug) $1,152
- NEUROSTAR TMS THERAPY SYSTEM (Device) $1,111
- CAPLYTA (Drug) $1,002
- REXULTI (Drug) $823.14
- ABILIFY MAINTENA (Drug) $772.13
- INGREZZA (Drug) $491.77
- ARISTADA (Drug) $409.38
- INVEGA SUSTENNA (Drug) $392.23
- AUSTEDO (Drug) $319.37
- Azstarys (Drug) $318.06
- TRINTELLIX (Drug) $241.94
- QUVIVIQ (Drug) $241.15
- VIVITROL (Drug) $186.24
- ABILIFY MYCITE (Drug) $127.05
- Dyanavel XR (Drug) $125.80
- PERSERIS (Drug) $114.97
- Quillivant (Drug) $108.80
- VYVANSE (Drug) $105.13
- Auvelity (Drug) $97.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Frankfort
Allison Butler, Cnp, CNP
Family — Payments: $3,812
Family $3,812
Emily Goodlett, Aprn, APRN
Family — Payments: $3,616
Family $3,616
Victoria Cammack, Aprn, APRN
Family — Payments: $3,536
Family $3,536
Lena Nickell, Arnp, ARNP
Family — Payments: $1,906
Family $1,906
Sarah Lay, Aprn, APRN
Family — Payments: $1,763
Family $1,763
Mrs. Susan Thompson, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $1,423
Family $1,423